Biography
Dr. Lee Cohen is Director of the Perinatal and Reproductive Psychiatry Clinic Research Program within the Clinical Psychopharmacology Unit of Massachusetts General Hospital (MGH), as well as Associate Professor of Psychiatry at Harvard Medical School. The Perinatal Psychiatry Program, founded in 1987, is a women’s health center dedicated to the evaluation and treatment of psychiatric disorders associated with female reproductive function. He completed his residency training and a fellowship at MGH.
Dr. Cohen has been principal investigator on federally funded studies evaluating the risk of depressive relapse during pregnancy and the postpartum period as well as the relationship between mood disorder and reproductive endocrine function among women transitioning to menopause. He has published numerous original research articles in the area of women's mental health and has edited and contributed to several textbooks in the area of perinatal and reproductive psychiatry.
Dr. Cohen is past recipient of an NIMH Faculty Scholar Award and a Young Investigator Award from the National Association of Research in Schizophrenia and Depression (NARSAD). He has been honored with an Independent Investigator Award from NARSAD to study the course of bipolar illness in pregnancy and the postpartum period, and the Outstanding Psychiatrist Award for Research from the Massachusetts Psychiatric Society. Dr. Cohen currently serves on the Advisory Board to the Office of Research on Women's Health (ORWH) at the National Institute of Health.
Disclosure
Research Support
Astra-Zeneca Pharmaceuticals, Bayer HealthCare Pharmaceuticals, Berlex Laboratories, Eli Lilly & Company, Forest Laboratories Inc., GlaxoSmithKline, Janssen Pharmaceuticals, National Institute of Mental Health, National Institutes of Health, National Alliance for Research on Schizophrenia and Depression, Sepracor Inc., Stanley Medical Research Institute, Good Samaritan Foundation, van Ameringen Foundation Inc., Abbott Pharmaceuticals, Organon Inc., Sanofi-Synthelabo Inc., Pfizer Inc., and Wyeth-Ayerst Pharmaceuticals.
Speaking/Honoraria
Astra-Zeneca Pharmaceuticals, Berlex Pharmaceuticals, Eli Lilly & Company, Forest Laboratories Inc., GlaxoSmithKline, Janssen Pharmaceuticals, Pfizer Inc., and Wyeth-Ayerst Pharmaceuticals.
Advisory/Consulting
Eli Lilly & Company, GlaxoSmithKline, Janssen Pharmaceuticals, JDS/Noven Pharmaceuticals, Novartis Pharmaceuticals, Ortho-McNeil Pharmaceuticals, Pamlab, L.L.C, and Wyeth-Ayerst Pharmaceuticals.
Last updated: 7/27/2010
Courses
Special Topics in Management of Major Depressive Disorder and Related Mood Disorders
Psychopharmacology Updates: A Comprehensive Review of Evidence-Based Approaches
Special Topics in Management of Major Depressive Disorder and Related Mood Disorders
Mood Disturbance and Associated Symptoms Across the Reproductive Lifecycle of Women
Virtual Grand Rounds: Spring 2011 Series -- Individual Registration
Virtual Grand Rounds: Fall 2011 Series -- Individual Registration
Virtual Grand Rounds: Update on the psychotropic drug management of postpartum depression
Virtual Grand Rounds: Treatment of Mood disorders during pregnancy: Lessons from Two decades